Ginger S. Johnson
In addition to her responsibilities as President of Commercial BioConsulting, Ginger leads core assessment and strategic consulting engagements, with special emphasis on CNS-related categories.
Previously, Ginger was the Director of Life Science Research at Chase Capital Partners (now CCMP Capital), a multi-billion-dollar global private equity and venture capital firm, where her research and investment activities focused on high-growth opportunities in new and emerging areas within the pharmaceutical, biotechnology and medical device industries. As Associate Director of the Center for Biotechnology at Northwestern University, Ginger helped to develop an innovative graduate program that combines the science and business of biotechnology. Ginger spent eight years in basic and applied scientific research, primarily in the field of Alzheimer’s disease and other neurodegenerative diseases, at the National Institute of Mental Health and a start-up biotechnology company. Ginger has published multiple peer-reviewed articles and three issued patents.
Ginger earned her Bachelor of Science degree in Molecular Biology from University of Tennessee, a Doctorate in Molecular Biology from George Washington University in Washington, DC, and has completed graduate studies at the Kellogg Graduate School of Management at Northwestern University.